Skip to main content

RXR agonist IRX4204 enhances BCMA CAR-T-cell efficacy by suppressing ferroptosis via CHAC1 downregulation

Conferences
Wu, J; Zhou, Y; Burcher, K; Wirthlin, L; Makepeace, J; Noldner, P; Dash, P; Nikiforov, M; Shaz, B; Vuligonda, V; Sanders, M; Kang, Y
Published in: Blood
November 3, 2025

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Blood

DOI

EISSN

1528-0020

ISSN

0006-4971

Publication Date

November 3, 2025

Volume

146

Issue

Supplement 1

Start / End Page

3947 / 3947

Publisher

American Society of Hematology

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Wu, J., Zhou, Y., Burcher, K., Wirthlin, L., Makepeace, J., Noldner, P., … Kang, Y. (2025). RXR agonist IRX4204 enhances BCMA CAR-T-cell efficacy by suppressing ferroptosis via CHAC1 downregulation. In Blood (Vol. 146, pp. 3947–3947). American Society of Hematology. https://doi.org/10.1182/blood-2025-3947
Wu, Jian, Ying Zhou, Kimberly Burcher, Louisa Wirthlin, Jen Makepeace, Pamela Noldner, Pradyot Dash, et al. “RXR agonist IRX4204 enhances BCMA CAR-T-cell efficacy by suppressing ferroptosis via CHAC1 downregulation.” In Blood, 146:3947–3947. American Society of Hematology, 2025. https://doi.org/10.1182/blood-2025-3947.
Wu J, Zhou Y, Burcher K, Wirthlin L, Makepeace J, Noldner P, et al. RXR agonist IRX4204 enhances BCMA CAR-T-cell efficacy by suppressing ferroptosis via CHAC1 downregulation. In: Blood. American Society of Hematology; 2025. p. 3947–3947.
Wu, Jian, et al. “RXR agonist IRX4204 enhances BCMA CAR-T-cell efficacy by suppressing ferroptosis via CHAC1 downregulation.” Blood, vol. 146, no. Supplement 1, American Society of Hematology, 2025, pp. 3947–3947. Crossref, doi:10.1182/blood-2025-3947.
Wu J, Zhou Y, Burcher K, Wirthlin L, Makepeace J, Noldner P, Dash P, Nikiforov M, Shaz B, Vuligonda V, Sanders M, Kang Y. RXR agonist IRX4204 enhances BCMA CAR-T-cell efficacy by suppressing ferroptosis via CHAC1 downregulation. Blood. American Society of Hematology; 2025. p. 3947–3947.

Published In

Blood

DOI

EISSN

1528-0020

ISSN

0006-4971

Publication Date

November 3, 2025

Volume

146

Issue

Supplement 1

Start / End Page

3947 / 3947

Publisher

American Society of Hematology

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology